Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Benitec Biopharma Inc. (BNTC)
USD13.06
+0.08 (+0.58%)
US NASDAQ Healthcare Biotechnology
Address
3940 Trust Way 94545
Hayward, CA, US
Hayward, CA, US
CEO
Jerel A. Banks
Website
benitec.com
IPO
2014-06-24
CIK 1808898 ISIN US08205P2092
Description
Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to combat chronic hepatitis B virus infection. Established in 1995, Benitec Biopharma's main operations are situated in Hayward, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD13.06
+0.08 (+0.58%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
116.3K
Beta
0.28
Float Shares
25.21M
Free Float %
96.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.72% | -1.66% | -10.57% | +14.16% | -9.95% | -12.03% | -12.74% | +225.55% | -84.51% | -97.20% | -99.80% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
13.06
Low
25.00
+91.5%
Consensus
28.50
+118.3%
Median
28.50
+118.3%
High
32.00
+145.1%
DCF (Unlevered)
2.67
-79.5%
DCF (Levered)
2.68
-79.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
25.00
+91.5%
|
| Last Quarter | 1 |
25.00
+91.5%
|
| Last Year | 5 |
28.60
+119.1%
|
| All Time | 9 |
24.44
+87.2%
|
Quality scores
Altman Z-Score
48.26
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+60.8% ★ Q1'26: +0.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-10,441.3% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+252.4% Q1'26: +27.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.02× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 6 Rev. Ana. 4 EPS Ana. |
Jun 2027 4 Rev. Ana. 4 EPS Ana. |
Jun 2028 2 Rev. Ana. 2 EPS Ana. |
Jun 2029 1 Rev. Ana. 1 EPS Ana. |
Jun 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
829.1K
est: 291.0K (+184.9%)
|
346.5K
est: 1.90M (-81.8%)
|
450.3K
est: 83.67M (-99.5%)
|
11.32M
est: 147.13M (-92.3%)
|
97.0K
est: 356.2K (-72.8%)
|
59.0K
est: 110.0K (-46.4%)
|
73.0K
est: 100.0K (-27.0%)
|
75.0K
est: 49.8K (+50.6%)
|
—
est: 100.0K (-100.0%)
|
—
est: 750.0K (-100.0%)
|
25.43M
25.43M – 25.43M
+3,290.5% YoY
|
36.43M
36.43M – 36.43M
+43.3% YoY
|
71.10M
71.10M – 71.10M
+95.2% YoY
|
131.05M
131.05M – 131.05M
+84.3% YoY
|
54.30M
54.30M – 54.30M
-58.6% YoY
|
| EBITDA |
-7.93M
est: -58.2K (-13,527.4%)
|
-13.42M
est: -379.8K (-3,433.0%)
|
-4.19M
est: -16.73M (+75.0%)
|
2.74M
est: -29.43M (+109.3%)
|
-7.91M
est: -71.2K (-10,997.9%)
|
-13.45M
est: -22.0K (-61,048.2%)
|
-17.85M
est: -20.0K (-89,174.5%)
|
-19.15M
est: -10.0K (-192,129.7%)
|
-21.41M
est: -20.0K (-106,945.4%)
|
-41.70M
est: -150.0K (-27,697.3%)
|
-5.09M
-5.09M – -5.09M
-3,290.5% YoY
|
-7.29M
-7.29M – -7.29M
-43.3% YoY
|
-14.22M
-14.22M – -14.22M
-95.2% YoY
|
-26.21M
-26.21M – -26.21M
-84.3% YoY
|
-10.86M
-10.86M – -10.86M
+58.6% YoY
|
| EBIT |
-8.01M
est: -58.2K (-13,655.2%)
|
-15.96M
est: -379.8K (-4,102.6%)
|
-4.36M
est: -16.73M (+74.0%)
|
2.58M
est: -29.43M (+108.8%)
|
-8.28M
est: -71.2K (-11,522.8%)
|
-13.88M
est: -22.0K (-62,975.6%)
|
-18.18M
est: -20.0K (-90,784.5%)
|
-19.53M
est: -10.0K (-195,954.6%)
|
-21.75M
est: -20.0K (-108,660.4%)
|
-41.77M
est: -150.0K (-27,743.5%)
|
-5.09M
-5.09M – -5.09M
-3,290.5% YoY
|
-7.29M
-7.29M – -7.29M
-43.3% YoY
|
-14.22M
-14.22M – -14.22M
-95.2% YoY
|
-26.21M
-26.21M – -26.21M
-84.3% YoY
|
-10.86M
-10.86M – -10.86M
+58.6% YoY
|
| Net Income |
-8.83M
est: -49.90M (+82.3%)
|
-18.50M
est: -1.56B (+98.8%)
|
-4.37M
est: -168.51M (+97.4%)
|
2.87M
est: -175.14M (+101.6%)
|
-8.27M
est: -15.66M (+47.2%)
|
-13.88M
est: -2.12B (+99.3%)
|
-18.21M
est: -1.16B (+98.4%)
|
-19.56M
est: -480.13M (+95.9%)
|
-21.75M
est: -173.44M (+87.5%)
|
-37.92M
est: -41.82M (+9.3%)
|
-40.06M
-42.57M – -37.54M
+4.2% YoY
|
-38.93M
-42.22M – -35.63M
+2.8% YoY
|
-54.49M
-70.96M – -38.03M
-40.0% YoY
|
-80.75M
-80.75M – -80.75M
-48.2% YoY
|
-68.80M
-68.80M – -68.80M
+14.8% YoY
|
| SGA |
6.17M
est: 16.50M (-62.6%)
|
8.96M
est: 107.64M (-91.7%)
|
6.99M
est: 4.74B (-99.9%)
|
6.66M
est: 8.34B (-99.9%)
|
5.57M
est: 20.19M (-72.4%)
|
6.51M
est: 6.24M (+4.4%)
|
6.65M
est: 5.67M (+17.2%)
|
6.00M
est: 2.82M (+112.6%)
|
6.65M
est: 5.67M (+17.2%)
|
23.43M
est: 42.51M (-44.9%)
|
1.44B
1.44B – 1.44B
+3,290.5% YoY
|
2.07B
2.07B – 2.07B
+43.3% YoY
|
4.03B
4.03B – 4.03B
+95.2% YoY
|
7.43B
7.43B – 7.43B
+84.3% YoY
|
3.08B
3.08B – 3.08B
-58.6% YoY
|
| EPS |
-194.89
est: -1.38 (-14,040.8%)
|
-331.56
est: -43.10 (-669.3%)
|
-63.56
est: -4.65 (-1,265.6%)
|
28.45
est: -4.84 (+688.1%)
|
-69.09
est: -0.43 (-15,871.6%)
|
-27.27
est: -58.48 (+53.4%)
|
-19.31
est: -32.13 (+39.9%)
|
-14.12
est: -13.26 (-6.5%)
|
-2.68
est: -4.79 (+44.1%)
|
-1.05
est: -1.25 (+15.8%)
|
-1.11
-1.18 – -1.04
+10.9% YoY
|
-1.08
-1.17 – -0.98
+2.5% YoY
|
-1.51
-1.96 – -1.05
-38.9% YoY
|
-2.23
-2.23 – -2.23
-48.2% YoY
|
-1.90
-1.90 – -1.90
+14.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-20.83M
OE per share TTM
-0.50
Owner's Yield
-3.56%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
41.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
31
Total invested
23.75M
Insider transactions (90d)
0
Beneficial owners (>5%)
34
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CVI Investments, Inc. | 1.50M | 5.80% | — | — | — | 1.50M | CO | Cayman Islands | 2022-09-23 | ↗ |
| 2 | Heights Capital Management, Inc. | 1.50M | 5.80% | — | — | — | 1.50M | CO | Cayman Islands | 2022-09-23 | ↗ |
| 3 | HBM Healthcare Investments (Cayman) Ltd. | 849.9K | 9.99% | 849.9K | — | 849.9K | — | CO | Cayman Islands, British West Indies | 2024-04-29 | ↗ |
| 4 | Steven M. Oliveira | 791.2K | 8.89% | — | 791.2K | — | — | IN | U.S.A. | 2024-04-29 | ↗ |
| 5 | Aaron Cowen | 769.0K | 9.80% | — | 769.0K | — | 769.0K | HC, IN | Delaware | 2021-05-07 | ↗ |
| 6 | Averill Master Fund, Ltd. | 769.0K | 9.80% | — | 769.0K | — | 769.0K | CO | Delaware | 2021-05-07 | ↗ |
| 7 | Suvretta Capital Management, LLC | 769.0K | 9.80% | — | 769.0K | — | 769.0K | IA, OO | Delaware | 2021-05-07 | ↗ |
| 8 | Nemean Asset Management, LLC | 746.3K | 8.39% | — | 746.3K | — | — | CO | Florida | 2024-04-29 | ↗ |
| 9 | Devesh Gandhi | 587.5K | 7.20% | — | 587.5K | — | — | IN | United States | 2022-02-09 | ↗ |
| 10 | SilverArc Capital Management, LLC | 587.5K | 7.20% | — | 587.5K | — | — | IA | Delaware | 2022-02-09 | ↗ |
| 11 | Alex Noah Investors, Inc. | 423.5K | 5.39% | — | 423.5K | — | — | CO | Illinois | 2021-04-28 | ↗ |
| 12 | Jonathan I. Cope | 423.5K | 5.39% | — | 423.5K | — | — | IN | Illinois | 2021-04-28 | ↗ |
| 13 | Joshua B. Scheinfeld | 423.5K | 5.39% | — | 423.5K | — | — | IN | Illinois | 2021-04-28 | ↗ |
| 14 | Lincoln Park Capital Fund, LLC | 423.5K | 5.39% | — | 423.5K | — | — | OO | Illinois | 2021-04-28 | ↗ |
| 15 | Lincoln Park Capital, LLC | 423.5K | 5.39% | — | 423.5K | — | — | OO | Illinois | 2021-04-28 | ↗ |
| 16 | Rockledge Capital Corporation | 423.5K | 5.39% | — | 423.5K | — | — | CO | Illinois | 2021-04-28 | ↗ |
| 17 | EIN #00-0000000 | 206.2K | 9.90% | — | 206.2K | — | 206.2K | IA, HC | Jersey, Channel Islands | 2023-08-18 | ↗ |
| 18 | Adage Capital Management, L.P. | 189.2K | 7.50% | — | 189.2K | — | — | IA, PN | Delaware | 2023-08-25 | ↗ |
| 19 | Adage Capital Partners GP, L.L.C. | 189.2K | 7.50% | — | 189.2K | — | — | OO | Delaware | 2023-08-25 | ↗ |
| 20 | Adage Capital Partners, L.P. | 189.2K | 7.50% | — | 189.2K | — | — | PN | Delaware | 2023-08-25 | ↗ |
| 21 | Phillip Gross | 189.2K | 7.50% | — | 189.2K | — | — | IN | United States | 2023-08-25 | ↗ |
| 22 | Robert Atchinson | 189.2K | 7.50% | — | 189.2K | — | — | IN | United States | 2023-08-25 | ↗ |
| 23 | 00-0000000 | 180.4K | 8.70% | — | 180.4K | — | 180.4K | CO | Cayman Islands | 2023-08-18 | ↗ |
| 24 | Morgan Stanley | 84.7K | 1.80% | — | 84.7K | — | 84.7K | HC, CO | Delaware. | 2021-04-12 | ↗ |
| 25 | Morgan Stanley Capital Services LLC | 84.7K | 1.80% | — | 84.7K | — | 84.7K | CO | Delaware. | 2021-04-12 | ↗ |
| 26 | IRA financial trust FBO Steven M. Oliveira Roth IRA | 44.9K | 0.01% | — | 44.9K | — | — | OO | USA | 2024-04-29 | ↗ |
| 27 | s: Globis Capital Advisors, L.L.C. | 12.1K | 0.30% | — | 12.1K | — | 12.1K | OO | Delaware | 2021-02-12 | ↗ |
| 28 | s: Globis Capital Management, L.P. | 12.1K | 0.30% | — | 12.1K | — | 12.1K | PN | Delaware | 2021-02-12 | ↗ |
| 29 | s: Globis Capital Partners, L.P. | 12.1K | 0.30% | — | 12.1K | — | 12.1K | PN | Delaware | 2021-02-12 | ↗ |
| 30 | s: Globis Capital, L.L.C. | 12.1K | 0.30% | — | 12.1K | — | 12.1K | OO | Delaware | 2021-02-12 | ↗ |
| 31 | SCHEDULE 13D | 12.00 | 14.00% | — | 1.48M | — | 1.48M | CO | — | 2024-04-29 | ↗ |
| 32 | 2. | 10.00 | 6.90% | — | 180.0K | — | — | IA, HC, OO | Delaware | 2023-08-21 | ↗ |
| 33 | Hudson Bay Capital Management LP | — | 0.00% | — | — | — | — | PN | State of Delaware | 2022-02-08 | ↗ |
| 34 | Sander Gerber | — | 0.00% | — | — | — | — | IN | United States | 2022-02-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
31
-40 vs prev Q
New positions
11
Closed positions
51
Increased
24
Reduced
4
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | EMPERY ASSET MANAGEMENT, LP | 55.4K +55.4K (+100.0%) | 746.78M +746.8M (+100.0%) | 0.13% +0.134 pp | 0.66% +0.659 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 2 | SUVRETTA CAPITAL MANAGEMENT, LLC | 11.55M +1.7M (+16.9%) | 155.56M +17.0M (+12.3%) | 25.12% -2.155 pp | 3.19% -0.360 pp | USD9.79 +37.6% | 10 qtrs — |
| 3 | JANUS HENDERSON GROUP PLC | 2.91M +— (+0.0%) | 39.29M -1.4M (-3.5%) | 7.01% -1.029 pp | 0.02% -0.001 pp | USD10.77 +25.1% | 10 qtrs — |
| 4 | FRANKLIN RESOURCES INC | 2.20M -392.3K (-15.1%) | 29.60M -6.7M (-18.5%) | 5.29% -1.860 pp | 0.01% -0.002 pp | USD10.33 +30.4% | 10 qtrs — |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12M +148.1K (+7.5%) | 28.57M +890.9K (+3.2%) | 4.61% -0.835 pp | 0.04% -0.001 pp | USD10.18 +32.3% | 10 qtrs — |
| 6 | RA CAPITAL MANAGEMENT, L.P. | 1.85M +1.9M (+100.0%) | 24.92M +24.9M (+100.0%) | 4.02% +4.024 pp | 0.26% +0.255 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 7 | VANGUARD GROUP INC | 1.17M +182.6K (+18.4%) | 15.82M +1.9M (+13.7%) | 2.56% -0.185 pp | 0.00% +0.000 pp | USD11.26 +19.6% | 9 qtrs — |
| 8 | NANTAHALA CAPITAL MANAGEMENT, LLC | 1.04M +200.3K (+23.9%) | 13.99M +2.2M (+19.0%) | 2.50% +0.186 pp | 0.46% +0.054 pp | USD8.46 +59.2% | 7 qtrs — |
| 9 | BLACKROCK, INC. | 992.3K +46.8K (+5.0%) | 13.37M +101.3K (+0.8%) | 2.16% -0.453 pp | 0.00% +0.000 pp | USD12.40 +8.6% | 6 qtrs — |
| 10 | INFINITUM ASSET MANAGEMENT, LLC | 898.9K +398.9K (+79.8%) | 12.11M +5.1M (+72.6%) | 2.16% +0.784 pp | 1.79% +0.502 pp | USD13.17 +2.3% | 5 qtrs — |
| 11 | SIREN, L.L.C. | 775.0K +775.0K (+100.0%) | 10.44M +10.4M (+100.0%) | 1.87% +1.867 pp | 0.31% +0.311 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 12 | ALYESKA INVESTMENT GROUP, L.P. | 750.0K +750.0K (+100.0%) | 10.10M +10.1M (+100.0%) | 1.63% +1.632 pp | 0.03% +0.029 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 13 | SILVERARC CAPITAL MANAGEMENT, LLC | 731.7K +455.5K (+164.9%) | 9.86M +6.0M (+154.3%) | 1.76% +0.999 pp | 1.37% +0.846 pp | USD13.32 +1.1% | 4 qtrs — |
| 14 | BALYASNY ASSET MANAGEMENT L.P. | 651.6K +651.6K (+100.0%) | 8.78M +8.8M (+100.0%) | 1.57% +1.569 pp | 0.01% +0.011 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 15 | MILLENNIUM MANAGEMENT LLC | 613.2K +613.2K (+100.0%) | 8.26M +8.3M (+100.0%) | 1.33% +1.334 pp | 0.00% +0.004 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 453.4K +14.9K (+3.4%) | 6.11M -45.4K (-0.7%) | 0.99% -0.225 pp | 0.00% +0.000 pp | USD11.38 +18.4% | 10 qtrs — |
| 17 | LONGAEVA PARTNERS L.P. | 290.0K +252.5K (+672.6%) | 3.91M +3.4M (+641.7%) | 0.63% +0.527 pp | 0.33% +0.252 pp | USD13.41 +0.4% | 4 qtrs — |
| 18 | AWM INVESTMENT COMPANY, INC. | 283.0K +100.0K (+54.7%) | 3.81M +1.2M (+48.5%) | 0.68% +0.176 pp | 0.37% +0.127 pp | USD11.96 +12.6% | 6 qtrs — |
| 19 | AMERIPRISE FINANCIAL INC | 280.7K +126.3K (+81.8%) | 3.78M +1.6M (+74.5%) | 0.68% +0.250 pp | 0.00% +0.000 pp | USD12.80 +5.2% | 6 qtrs — |
| 20 | SCHONFELD STRATEGIC ADVISORS LLC | 262.2K +1.8K (+0.7%) | 3.53M -121.8K (-3.3%) | 0.63% -0.088 pp | 0.02% -0.005 pp | USD7.42 +81.5% | 7 qtrs — |
| 21 | STATE STREET CORP | 245.1K +26.7K (+12.2%) | 3.30M +236.7K (+7.7%) | 0.53% -0.070 pp | 0.00% +0.000 pp | USD12.53 +7.5% | 5 qtrs — |
| 22 | MYDA ADVISORS LLC | 225.0K +155.0K (+221.4%) | 3.03M +2.0M (+208.6%) | 0.49% +0.296 pp | 0.58% +0.365 pp | USD13.22 +1.9% | 5 qtrs — |
| 23 | GOLDMAN SACHS GROUP INC | 174.0K -20.3K (-10.5%) | 2.34M -382.6K (-14.0%) | 0.38% -0.158 pp | 0.00% +0.000 pp | USD13.92 -3.2% | 4 qtrs — |
| 24 | SIMPLIFY ASSET MANAGEMENT INC. | 151.2K +72.4K (+92.0%) | 2.04M +931.7K (+84.3%) | 0.36% +0.147 pp | 0.03% +0.013 pp | USD11.17 +20.6% | 7 qtrs — |
| 25 | BURKEHILL GLOBAL MANAGEMENT, LP | 150.0K +150.0K (+100.0%) | 2.02M +2.0M (+100.0%) | 0.33% +0.326 pp | 0.13% +0.133 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 26 | NORTHERN TRUST CORP | 126.2K -4.5K (-3.4%) | 1.70M -133.2K (-7.3%) | 0.30% -0.057 pp | 0.00% +0.000 pp | USD11.11 +21.2% | 7 qtrs — |
| 27 | WOODLINE PARTNERS LP | 100.7K +100.7K (+100.0%) | 1.36M +1.4M (+100.0%) | 0.22% +0.219 pp | 0.01% +0.005 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 28 | UBS GROUP AG | 98.3K -1.6K (-1.6%) | 1.32M -77.4K (-5.5%) | 0.21% -0.062 pp | 0.00% +0.000 pp | USD13.60 -1.0% | 10 qtrs — |
| 29 | LION POINT CAPITAL, LP | 62.0K +— (+0.0%) | 835.1K -34.7K (-4.0%) | 0.15% -0.022 pp | 4.32% -0.620 pp | USD10.47 +28.7% | 6 qtrs — |
| 30 | MORGAN STANLEY | 58.8K +42.7K (+264.9%) | 792.2K +566.1K (+250.3%) | 0.13% +0.083 pp | 0.00% +0.000 pp | USD13.13 +2.6% | 9 qtrs — |
| 31 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 45.3K +— (+0.0%) | 609.8K -25.4K (-4.0%) | 0.11% -0.016 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 32 | MARSHALL WACE, LLP | 35.7K +35.7K (+100.0%) | 480.7K +480.7K (+100.0%) | 0.08% +0.078 pp | 0.00% +0.000 pp | USD13.47 +0.0% | 3 qtrs — |
| 33 | BANK OF NEW YORK MELLON CORP | 31.6K -2.4K (-7.0%) | 425.8K -51.2K (-10.7%) | 0.08% -0.018 pp | 0.00% +0.000 pp | USD11.84 +13.8% | 3 qtrs — |
| 34 | QUADRATURE CAPITAL LTD | 31.5K +31.5K (+100.0%) | 424.0K +424.0K (+100.0%) | 0.07% +0.069 pp | 0.00% +0.004 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 35 | BARCLAYS PLC | 23.2K +1.9K (+9.1%) | 312.7K +14.1K (+4.7%) | 0.05% -0.008 pp | 0.00% +0.000 pp | USD11.85 +13.7% | 3 qtrs — |
| 36 | PERSISTENT ASSET PARTNERS LTD | 20.8K +20.8K (+100.0%) | 279.5K +279.5K (+100.0%) | 0.05% +0.045 pp | 0.13% +0.126 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 37 | NUVEEN, LLC | 18.8K +— (+0.0%) | 253.0K -10.5K (-4.0%) | 0.04% -0.011 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 38 | RHUMBLINE ADVISERS | 17.7K -2.9K (-13.9%) | 238.0K -50.0K (-17.4%) | 0.04% -0.018 pp | 0.00% +0.000 pp | USD11.62 +15.9% | 10 qtrs — |
| 39 | CITADEL ADVISORS LLC | 17.6K +17.6K (+100.0%) | 236.8K +236.8K (+100.0%) | 0.04% +0.038 pp | 0.00% +0.000 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 40 | WELLS FARGO & COMPANY/MN | 16.3K +7.1K (+78.1%) | 219.0K +90.9K (+71.0%) | 0.04% +0.010 pp | 0.00% +0.000 pp | USD12.71 +6.0% | 3 qtrs — |
| 41 | SQUAREPOINT OPS LLC | 15.0K +15.0K (+100.0%) | 202.7K +202.7K (+100.0%) | 0.04% +0.036 pp | 0.00% +0.000 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 42 | HRT FINANCIAL LP | 13.3K +13.3K (+100.0%) | 178.0K +178.0K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.001 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 43 | JANE STREET GROUP, LLC | 12.4K +12.4K (+100.0%) | 167.4K +167.4K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.000 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 44 | DEUTSCHE BANK AG\ | 12.3K -4.4K (-26.5%) | 165.8K -69.2K (-29.4%) | 0.03% -0.017 pp | 0.00% +0.000 pp | USD12.51 +7.7% | 3 qtrs — |
| 45 | BANK OF AMERICA CORP /DE/ | 12.1K +4.6K (+60.4%) | 163.3K +57.3K (+54.0%) | 0.03% +0.006 pp | 0.00% +0.000 pp | USD12.49 +7.8% | 7 qtrs — |
| 46 | METLIFE INVESTMENT MANAGEMENT, LLC | 9.4K +— (+0.0%) | 126.6K -5.3K (-4.0%) | 0.02% -0.003 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 47 | SG AMERICAS SECURITIES, LLC | 8.2K +8.2K (+100.0%) | 111.0K +111.0K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 48 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 6.9K +119.0 (+1.8%) | 93.0K -2.2K (-2.3%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD11.73 +14.8% | 3 qtrs — |
| 49 | GAMMA INVESTING LLC | 6.7K -1.0 (0.0%) | 90.6K -3.8K (-4.0%) | 0.01% -0.004 pp | 0.00% -0.001 pp | USD7.18 +87.6% | 9 qtrs — |
| 50 | RUSSELL INVESTMENTS GROUP, LTD. | 6.2K +603.0 (+10.7%) | 83.8K +5.0K (+6.3%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD13.98 -3.6% | 2 qtrs — |
| 51 | JPMORGAN CHASE & CO | 6.0K +39.0 (+0.7%) | 81.2K -2.8K (-3.4%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD11.71 +15.0% | 3 qtrs — |
| 52 | NEW YORK STATE COMMON RETIREMENT FUND | 4.3K +— (+0.0%) | 58.3K -2.4K (-4.0%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 53 | BNP PARIBAS ARBITRAGE, SNC | 4.1K +1.1K (+38.2%) | 54.7K +13.5K (+32.7%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD12.71 +6.0% | 3 qtrs — |
| 54 | TRUVESTMENTS CAPITAL LLC | 3.8K +2.3K (+156.5%) | 51.6K +30.7K (+146.2%) | 0.01% +0.005 pp | 0.01% +0.006 pp | USD12.97 +3.9% | 3 qtrs — |
| 55 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 3.2K +— (+0.0%) | 43.4K -1.8K (-4.0%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 56 | ROYAL BANK OF CANADA | 2.1K -1.5K (-41.2%) | 29.0K -22.0K (-43.1%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD14.00 -3.8% | 5 qtrs — |
| 57 | LEGAL & GENERAL GROUP PLC | 1.5K -81.0 (-5.0%) | 20.6K -2.0K (-8.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 58 | AMERITAS INVESTMENT PARTNERS, INC. | 1.5K +— (+0.0%) | 19.9K -827.0 (-4.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 59 | FMR LLC | 1.3K +110.0 (+9.2%) | 17.7K +809.0 (+4.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD13.66 -1.4% | 3 qtrs — |
| 60 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 915.00 +11.0 (+1.2%) | 12.3K -358.0 (-2.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD11.72 +14.9% | 3 qtrs — |
| 61 | TOWER RESEARCH CAPITAL LLC (TRC) | 723.00 -357.0 (-33.1%) | 9.7K -5.4K (-35.7%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD13.07 +3.1% | 10 qtrs — |
| 62 | CITIGROUP INC | 544.00 -92.0 (-14.5%) | 7.3K -1.6K (-17.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD12.63 +6.7% | 5 qtrs — |
| 63 | AMALGAMATED BANK | 467.00 -27.0 (-5.5%) | 6.0K -1.0K (-14.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD11.70 +15.1% | 3 qtrs — |
| 64 | US BANCORP \DE\ | 202.00 +202.0 (+100.0%) | 2.7K +2.7K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 65 | QUADRANT CAPITAL GROUP LLC | 173.00 +173.0 (+100.0%) | 2.3K +2.3K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD13.47 +0.0% | 1 qtrs NEW |
| 66 | PNC FINANCIAL SERVICES GROUP, INC. | 147.00 +142.0 (+2,840.0%) | 2.0K +1.9K (+2,728.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD13.48 -0.1% | 2 qtrs — |
| 67 | STERLING CAPITAL MANAGEMENT LLC | 97.00 +61.0 (+169.4%) | 1.3K +802.0 (+158.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.82 +5.1% | 3 qtrs — |
| 68 | GROUP ONE TRADING, L.P. | 89.00 +— (+0.0%) | 1.2K -50.0 (-4.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.01 +347.5% | 10 qtrs — |
| 69 | PARALLEL ADVISORS, LLC | 55.00 +55.0 (+100.0%) | 741.00 +741.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD13.45 +0.1% | 1 qtrs NEW |
| 70 | ADVISOR GROUP HOLDINGS, INC. | 1.00 +1.0 (+100.0%) | 13.00 +13.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD13.00 +3.6% | 1 qtrs NEW |
| 71 | IFP ADVISORS, INC | 1.00 +— (+0.0%) | 13.00 -1.0 (-7.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.00 -3.8% | 2 qtrs — |
| 72 | SRS CAPITAL ADVISORS, INC. | — -24.0 (-100.0%) | — -337.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 73 | SIMPLEX TRADING, LLC | — -72.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 74 | SBI SECURITIES CO., LTD. | — -1.0 (-100.0%) | — -14.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 75 | EXODUSPOINT CAPITAL MANAGEMENT, LP | — -77.9K (-100.0%) | — -1.1M (-100.0%) | 0.00% -0.215 pp | 0.00% -0.011 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 42 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Simplify Health Care ETF PINK | 3.73% | 14.23M | 0.51% |
| 2 | Global X - Genomics & Biotechnology ETF GNOM | 0.39% | 338.0K | 0.50% |
| 3 | Global X - Genomics & Biotechnology UCITS ETF GNOM.L | 0.39% | 202.1K | 0.50% |
| 4 | iShares Micro-Cap ETF IWC | 0.06% | 959.9K | 0.60% |
| 5 | iShares Russell 2000 Value ETF IWN | 0.02% | 2.50M | 0.24% |
| 6 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 207.3K | 0.06% |
| 7 | Global X - Russell 2000 ETF RSSL | 0.01% | 133.8K | 0.08% |
| 8 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.01% | 28.9K | 0.25% |
| 9 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 5.0K | 0.39% |
| 10 | iShares Russell 2000 ETF IWM | 0.01% | 7.30M | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
23
Sells
0
Shares acquired
2.99M
Shares disposed
—
Cash buys
14.00
Cash sales
—
Net activity
+2,993,862
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-22 | Mates Sharon | Director | A-Award | A | Options (right to buy) | 31,500 | 12.83 | 404.1K | 31,500 | D | ↗ |
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 65,800 | 13.44 | 884.4K | 9,700,195 | I | ↗ |
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 14,320 | 13.10 | 187.6K | 9,634,395 | I | ↗ |
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 42,600 | 12.85 | 547.4K | 9,620,075 | I | ↗ |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 2,892 | 12.08 | 34.9K | 1,826,653 | I | ↗ |
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 13,950 | 11.48 | 160.1K | 9,560,825 | I | ↗ |
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 1,515 | 11.24 | 17.0K | 1,821,327 | I | ↗ |
| 2025-12-01 | Smith Edward F | Director | A-Award | A | Options (right to buy) | 35,000 | 12.23 | 428.1K | 35,000 | D | ↗ |
| 2025-12-01 | Mehta Kishan | Director | A-Award | A | Options (right to buy) | 35,000 | 12.23 | 428.1K | 35,000 | D | ↗ |
| 2025-12-01 | Mates Sharon | Director | A-Award | A | Options (right to buy) | 3,500 | 12.23 | 42.8K | 3,500 | D | ↗ |
| 2025-12-01 | Francis Peter | Director | A-Award | A | Options (right to buy) | 35,000 | 12.23 | 428.1K | 35,000 | D | ↗ |
| 2025-12-01 | BUCHI J KEVIN | Director | A-Award | A | Options (right to buy) | 35,000 | 12.23 | 428.1K | 35,000 | D | ↗ |
| 2025-11-18 | Mukadam Sophie | Officer | A-Award | A | Options (right to buy) | 500,000 | 13.53 | 6.77M | 500,000 | D | ↗ |
| 2025-11-18 | Boston Megan | Director / Officer | A-Award | A | Options (right to buy) | 200,000 | 13.53 | 2.71M | 200,000 | D | ↗ |
| 2025-11-18 | Banks Jerel A. | Director / Officer | A-Award | A | Options (right to buy) | 450,000 | 13.53 | 6.09M | 450,000 | D | ↗ |
| 2025-11-07 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 730,370 | 13.50 | 9.86M | 9,538,175 | I | ↗ |
| 2025-11-05 | Mates Sharon | Director | A-Award | A | Options (right to buy) | 28,517 | 15.78 | 450.0K | 28,517 | D | ↗ |
| 2025-11-03 | Mates Sharon | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 9,503 | 12.63 | 120.0K | 8,802,748 | I | ↗ |
| 2025-03-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 793,800 | 13.00 | 10.32M | 8,793,245 | I | ↗ |
| 2025-03-12 | BUCHI J KEVIN | Director | G-Gift | A | Common Stock | 103,626 | 0.00 | — | 103,626 | I | ↗ |
| 2025-02-27 | BUCHI J KEVIN | Director | M-Exempt | A | Common Stock | 51,813 | 3.86 | 200.0K | 103,910 | D | ↗ |
| 2025-01-01 | Mukadam Sophie | Officer | — | — | Options (right to buy) | 100,000 | 5.21 | 521.0K | 0 | D | ↗ |
| 2024-12-24 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 2,288 | 11.25 | 25.7K | 960,554 | I | ↗ |
| 2024-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 24,360 | 10.98 | 267.5K | 7,981,725 | I | ↗ |
| 2024-12-09 | Smith Edward F | Director | A-Award | A | Options (right to buy) | 35,000 | 12.18 | 426.3K | 35,000 | D | ↗ |
| 2024-12-09 | Mehta Kishan | Director | A-Award | A | Options (right to buy) | 35,000 | 12.18 | 426.3K | 35,000 | D | ↗ |
| 2024-12-09 | Francis Peter | Director | A-Award | A | Options (right to buy) | 35,000 | 12.18 | 426.3K | 35,000 | D | ↗ |
| 2024-12-09 | Boston Megan | Director / Officer | A-Award | A | Options (right to buy) | 720,000 | 12.18 | 8.77M | 720,000 | D | ↗ |
| 2024-12-09 | Banks Jerel A. | Director / Officer | A-Award | A | Options (right to buy) | 2,310,000 | 12.18 | 28.14M | 2,310,000 | D | ↗ |
| 2024-12-09 | BUCHI J KEVIN | Director | A-Award | A | Options (right to buy) | 35,000 | 12.18 | 426.3K | 35,000 | D | ↗ |
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 37,190 | 9.60 | 357.0K | 7,957,365 | I | ↗ |
| 2024-11-20 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 24,360 | 10.22 | 249.0K | 7,920,175 | I | ↗ |
| 2024-11-19 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | P-Purchase | A | Common stock, par value $0.0001 per share | 12,430 | 9.73 | 120.9K | 7,895,815 | I | ↗ |
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director / 10% Owner | X-InTheMoney | D | Common Warrants | 576,347 | 3.86 | 2.22M | 0 | I | ↗ |
| 2024-06-26 | Mehta Kishan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-04-22 | SUVRETTA CAPITAL MANAGEMENT, LLC | 10% Owner | — | I | Pre-Funded Warrants | 276,353 | 0.00 | 27.64 | 0 | — | ↗ |
| 2024-03-06 | Boston Megan | Director / Officer | A-Award | A | Options (right to buy) | 200,004 | 5.21 | 1.04M | 200,004 | — | ↗ |
| 2024-03-06 | Banks Jerel A. | Director / Officer | A-Award | A | Options (right to buy) | 466,554 | 5.21 | 2.43M | 466,554 | — | ↗ |
| 2023-12-06 | Smith Edward F | Director | A-Award | A | Options (right to buy) | 35,000 | 3.13 | 109.6K | 35,000 | — | ↗ |
| 2023-12-06 | Francis Peter | Director | A-Award | A | Options (right to buy) | 35,000 | 3.13 | 109.6K | 35,000 | — | ↗ |
| 2023-12-06 | BUCHI J KEVIN | Director | A-Award | A | Options (right to buy) | 35,000 | 3.13 | 109.6K | 35,000 | — | ↗ |
| 2023-08-11 | SUVRETTA CAPITAL MANAGEMENT, LLC | 10% Owner | — | I | Common Warrants | 576,347 | 3.86 | 2.22M | 0 | — | ↗ |
| 2023-08-11 | Boston Megan | Director / Officer | P-Purchase | A | Common Stock | 25,907 | 0.00 | 2.59 | 25,907 | — | ↗ |
| 2023-08-11 | BUCHI J KEVIN | Director | P-Purchase | A | Common Warrants (right to buy) | 51,813 | 3.86 | 200.0K | 51,813 | — | ↗ |
| 2023-06-13 | Boston Megan | Director / Officer | A-Award | A | Options (right to buy) | 153,000 | 0.23 | 35.2K | 153,000 | — | ↗ |
| 2023-06-13 | Banks Jerel A. | Director / Officer | A-Award | A | Options (right to buy) | 356,900 | 0.23 | 82.1K | 356,900 | — | ↗ |
| 2022-12-09 | SUVRETTA CAPITAL MANAGEMENT, LLC | 10% Owner | — | I | Series 2 Common Warrants | 588,236 | 1.93 | 1.14M | 0 | — | ↗ |
| 2022-12-07 | Smith Edward F | Director | A-Award | A | Options (right to buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-12-07 | Francis Peter | Director | A-Award | A | Options (right to buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-12-07 | BUCHI J KEVIN | Director | A-Award | A | Options (right to buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-09-15 | SUVRETTA CAPITAL MANAGEMENT, LLC | 10% Owner | — | I | Pre-Funded Warrants | 588,235 | 0.00 | 1,000.00 | 0 | — | ↗ |
| 2021-12-09 | Oliveira Steven Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0,0001 per share | 10,553 | 3.04 | 32.1K | 1,000,000 | — | ↗ |
| 2021-12-08 | Smith Edward F | Director | A-Award | A | Options (right to buy) | 12,000 | 2.99 | 35.9K | 12,000 | — | ↗ |
| 2021-12-08 | Francis Peter | Director | A-Award | A | Options (right to buy) | 12,000 | 2.99 | 35.9K | 12,000 | — | ↗ |
| 2021-12-08 | BUCHI J KEVIN | Director | A-Award | A | Options (right to buy) | 12,000 | 2.99 | 35.9K | 12,000 | — | ↗ |
| 2021-11-29 | Oliveira Steven Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0,0001 per share | 37,947 | 3.18 | 120.7K | 989,447 | — | ↗ |
| 2021-05-03 | Oliveira Steven Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0,0001 per share | 40,500 | 4.25 | 172.3K | 951,500 | — | ↗ |
| 2021-04-30 | Oliveira Steven Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0,0001 per share | 120,000 | 4.18 | 501.9K | 911,000 | — | ↗ |
| 2021-04-29 | Oliveira Steven Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0,0001 per share | 22,877 | 5.49 | 125.6K | 791,000 | — | ↗ |
| 2021-04-28 | Oliveira Steven Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0,0001 per share | 100,000 | 5.45 | 544.9K | 768,123 | — | ↗ |
| 2021-04-12 | Oliveira Steven Michael | 10% Owner | — | I | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 668,123 | — | ↗ |
| 2020-12-09 | Smith Edward F | Director | A-Award | A | Options (right to buy) | 23,601 | 2.98 | 70.3K | 23,601 | — | ↗ |
| 2020-12-09 | Francis Peter | Director | A-Award | A | Options (right to buy) | 23,601 | 2.98 | 70.3K | 23,601 | — | ↗ |
| 2020-12-09 | Boston Megan | Director / Officer | A-Award | A | Options (right to buy) | 142,172 | 2.98 | 423.7K | 142,172 | — | ↗ |
| 2020-12-09 | Banks Jerel A. | Director / Officer | A-Award | A | Options (right to buy) | 284,345 | 2.98 | 847.3K | 284,345 | — | ↗ |
| 2020-12-09 | BUCHI J KEVIN | Director | A-Award | A | Options (right to buy) | 23,601 | 2.98 | 70.3K | 23,601 | — | ↗ |
| 2020-04-15 | Smith Edward F | Director | — | D | No securities are beneficially owned | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-04-15 | Nant Capital, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 97,686 | — | ↗ |
| 2020-04-15 | Francis Peter | Director | — | D | Common Stock | 0 | 0.00 | — | 300 | — | ↗ |
| 2020-04-15 | Boston Megan | Director / Officer | — | I | Common Stock | 0 | 0.00 | — | 333 | — | ↗ |
| 2020-04-15 | Banks Jerel A. | Director / Officer | — | D | Options (right to buy) | 33,333 | 108.00 | 3.60M | 0 | — | ↗ |
| 2020-04-15 | BUCHI J KEVIN | Director | — | D | Common Stock | 0 | 0.00 | — | 4,827 | — | ↗ |
Executive team
Top executives
Shares Outstanding
26.25M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jerel A. Banks | Executive Chairman & Chief Executive Officer | 1M | — |
| Sophie Mukadam | Chief Operating Officer | 940.4K | female |
| Megan Joan Boston | Chief Financial Officer, Secretary & Director | 870.8K | female |
| Michael Graham | Head of Discovery & Founding Scientist | 140.0K | — |
| Claudia Kloth | Senior Vice President of Manufacturing | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BNTC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
